Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 346 to 360 of 866 results for score

  1. Joint distraction for knee osteoarthritis without alignment correction (IPG529)

    Evidence-based recommendations on joint distraction for knee osteoarthritis without alignment correction. This involves fixing a metal frame around the knee to take weight off the joint and encourage the cartilage to repair itself.

    Interventional procedures guidance
    Published
    23 July 2015
    View recommendations

    Sections for IPG529

  2. The MIST Therapy system for the promotion of wound healing (HTG267)

    Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing.

    HealthTech guidance
    Published
    25 July 2011
    View recommendations

    Sections for HTG267

  3. Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)

    Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis

    Evidence summary
    Published
    21 July 2020

  4. Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTG748)

    Early value assessment (EVA) guidance on digital therapy for chronic tic disorders and Tourette syndrome.

    HealthTech guidance
    Published
    7 May 2025
    View recommendations

    Sections for HTG748

  5. Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids (TA832)

    Evidence-based recommendations on relugolix–estradiol–norethisterone acetate (Ryeqo) for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.

    Technology appraisal guidance
    Published
    19 October 2022
    View recommendations

    Sections for TA832

  6. Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)

    Evidence-based recommendations on relugolix–estradiol–norethisterone (Ryeqo) for treating symptoms of endometriosis in adults of reproductive age.

    Technology appraisal guidance
    Published
    16 April 2025

    Sections for TA1057

  7. Percutaneous mitral valve annuloplasty (IPG352)

    Evidence-based recommendations on percutaneous mitral valve annuloplasty. This involves inserting a catheter into a large vein in the groin or neck and passing through to the heart. A device is placed into a large vein that sits next to the mitral valve to constrict the valve, with the aim of making it close properly.

    Interventional procedures guidance
    Published
    28 July 2010
    View recommendations

    Sections for IPG352

  8. Haemorrhoidal artery ligation (IPG342)

    Evidence-based recommendations on haemorrhoidal artery ligation. This involves tying the blood vessels and folding up the inside lining of the bowel to reduce blood supply to the haemorrhoids and make them shrink.

    Interventional procedures guidance
    Published
    19 May 2010
    View recommendations

    Sections for IPG342

  9. Endometrial cryotherapy for menorrhagia (IPG157)

    Evidence-based recommendations on endometrial cryotherapy for menorrhagia (heavy periods). This involves using cold temperatures to freeze and destroy the lining of the womb.

    Interventional procedures guidance
    Published
    22 March 2006
    View recommendations

    Sections for IPG157

  10. FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)

    NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome .

    Medtech innovation briefing
    Published
    7 December 2021

  11. Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease (TA809)

    Evidence-based recommendations on imlifidase (Idefirix) for desensitisation treatment before kidney transplant in people with chronic kidney disease.

    Technology appraisal guidance
    Published
    20 July 2022
    View recommendations

    Sections for TA809

  12. Laparoscopic prostatectomy for benign prostatic obstruction (IPG275)

    Evidence-based recommendations on laparoscopic prostatectomy for benign prostatic obstruction. This involves removing the prostate through small cuts in the abdomen, using a fine telescope to see inside the body (keyhole surgery).

    Interventional procedures guidance
    Published
    26 November 2008
    View recommendations

    Sections for IPG275

  13. Gambling-related harms: identification, assessment and management (NG248)

    This guideline covers identifying, assessing and treating gambling-related harms. This includes people aged 18 and over who are experiencing gambling that harms, and people of any age affected by someone close to them who is experiencing gambling that harms.

    NICE guideline
    Published
    28 January 2025
    View recommendations

    Sections for NG248

  14. Scleral expansion surgery for presbyopia (IPG70)

    Evidence-based recommendations on scleral expansion surgery for presbyopia. This involves making small incisions in the eye and inserting bands to stretch part of the sclera.

    Interventional procedures guidance
    Published
    28 July 2004
    View recommendations

    Sections for IPG70

  15. Fetal vesico–amniotic shunt for lower urinary tract outflow obstruction (IPG202)

    Evidence-based recommendations on fetal vesico–amniotic shunt for lower urinary tract outflow obstruction. This involves inserting a cannula through the mother's abdominal and uterine walls into the amniotic cavity and subsequently into the bladder of the fetus.

    Interventional procedures guidance
    Published
    13 December 2006
    View recommendations

    Sections for IPG202